BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18341875)

  • 1. [Macrophage activation syndrome and juvenile idiopathic arthritis. A multicenter study].
    García-Consuegra Molina J; Merino Muñoz R; de Inocencio Arocena J;
    An Pediatr (Barc); 2008 Feb; 68(2):110-6. PubMed ID: 18341875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
    Li CF; He XH; Kuang WY; Han TX; Zhou YF
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
    Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
    Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
    Behrens EM; Beukelman T; Paessler M; Cron RQ
    J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience.
    Jelušić M; Kronja M; Frković M; Sršen S; Huljev Frković S; Štekić Novački K
    Acta Clin Croat; 2018 Jun; 57(2):307-311. PubMed ID: 30431724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.
    Sawhney S; Woo P; Murray KJ
    Arch Dis Child; 2001 Nov; 85(5):421-6. PubMed ID: 11668110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
    J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
    Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
    Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Minoia F; Davì S; Horne A; Bovis F; Demirkaya E; Akikusa J; Ayaz NA; Al-Mayouf SM; Barone P; Bica B; Bolt I; Breda L; De Cunto C; Enciso S; Gallizzi R; Griffin T; Hennon T; Horneff G; Jeng M; Kapovic AM; Lipton JM; Magni Manzoni S; Rumba-Rozenfelde I; Magalhaes CS; Sewairi WM; Stine KC; Vougiouka O; Weaver LK; Davidsone Z; De Inocencio J; Ioseliani M; Lattanzi B; Tezer H; Buoncompagni A; Picco P; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    J Rheumatol; 2015 Jun; 42(6):994-1001. PubMed ID: 25877504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
    Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.
    Sönmez HE; Demir S; Bilginer Y; Özen S
    Clin Rheumatol; 2018 Dec; 37(12):3329-3335. PubMed ID: 29663156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage Activation Syndrome in Paediatric Rheumatic Diseases.
    Islam MI; Talukder MK; Islam MM; Laila K; Rahman SA
    Mymensingh Med J; 2017 Apr; 26(2):356-363. PubMed ID: 28588173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.